Principal Investigator Lawrence Susskind
C Cem Tasan
The 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.
Principal Investigator Richard Temkin
AI’s influence is undeniable in the digital realm, affecting consumers’ lives and corporate operations. Transferring these advancements to sectors producing physical goods, such as drug discovery and biotech, commodity chemicals, materials for energy and sustainability, and manufacturing, presents a thrilling prospect and a translational challenge. This talk will explore the present use cases and the potential of applying generative AI within the chemistry and materials domain. Unlike a large part of the tech sector, these industries are capital-intensive and cautious, meaning that AI must bridge an “execution gap” between the digital and physical realms for value generation. We will outline strategies to overcome current technical and cultural hurdles.
Martin Bazant
Principal Investigator Adam Chlipala
Principal Investigator Yossi Sheffi
The pharmaceutical industry is under growing pressure from patent expirations of major drugs, cost-constrained health care systems, and a demanding regulatory environment. A focus for the industry is to tackle these challenges while increasing the output and quality of cost-effective, new medicines without incurring unsustainable R&D cost. Through new technology and new approaches there is an aspiration to make such improvements while also bringing ever-improved therapeutics to patients faster. In this conference, we will lay out many of the challenges the industry is facing and explore potential solutions coming from academic research and startup endeavors, from early discovery through manufacturing technologies, to clinical studies and beyond.